RCGE yields 1.84% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, RCGE + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RCGE + PFE for your $10,000?
RCGE is actively managed to provide exposure to a portfolio of companies committed to managing their organizations with a gender-balance approach. The eligible universe starts from the largest 3,000 stocks by market cap in developed markets, and the largest 1,000 stocks by market-cap in emerging markets. The fund filters stocks by looking at a companys gender equality score, which is based on gender balance, gender pay gap, and policies relating to parental leave and sexual harassment. Companies in which a score cannot be determined are excluded. An additional ethics screen is used to further narrow down the eligible universe. Lastly, the fund will look at a companys financial performance, mainly debt-to-equity ratio, debt-to EBITDA, and financial statement strength. The top 150 to 200 companies with the highest gender score that meet the financial criteria are selected. The fund imposes individual, countries, and sector caps. Rebalancing is done quarterly.
Full RCGE Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.